These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Proteus mirabilis uroepithelial cell adhesin (UCA) fimbria plays a role in the colonization of the urinary tract. Pellegrino R, Scavone P, Umpiérrez A, Maskell DJ, Zunino P. Pathog Dis; 2013 Mar; 67(2):104-7. PubMed ID: 23620155 [Abstract] [Full Text] [Related]
3. Mannose-resistant Proteus-like and P. mirabilis fimbriae have specific and additive roles in P. mirabilis urinary tract infections. Zunino P, Sosa V, Schlapp G, Allen AG, Preston A, Maskell DJ. FEMS Immunol Med Microbiol; 2007 Oct; 51(1):125-33. PubMed ID: 17854474 [Abstract] [Full Text] [Related]
8. Involvement of polyphosphate kinase in virulence and stress tolerance of uropathogenic Proteus mirabilis. Peng L, Jiang Q, Pan JY, Deng C, Yu JY, Wu XM, Huang SH, Deng XY. Med Microbiol Immunol; 2016 Apr; 205(2):97-109. PubMed ID: 26233310 [Abstract] [Full Text] [Related]
10. Repression of bacterial motility by a novel fimbrial gene product. Li X, Rasko DA, Lockatell CV, Johnson DE, Mobley HL. EMBO J; 2001 Sep 03; 20(17):4854-62. PubMed ID: 11532949 [Abstract] [Full Text] [Related]
11. Requirement of MrpH for mannose-resistant Proteus-like fimbria-mediated hemagglutination by Proteus mirabilis. Li X, Johnson DE, Mobley HL. Infect Immun; 1999 Jun 03; 67(6):2822-33. PubMed ID: 10338487 [Abstract] [Full Text] [Related]
12. MrpJ Directly Regulates Proteus mirabilis Virulence Factors, Including Fimbriae and Type VI Secretion, during Urinary Tract Infection. Debnath I, Stringer AM, Smith SN, Bae E, Mobley HLT, Wade JT, Pearson MM. Infect Immun; 2018 Oct 03; 86(10):. PubMed ID: 30082479 [Abstract] [Full Text] [Related]
13. Proteus mirabilis flagella and MR/P fimbriae: isolation, purification, N-terminal analysis, and serum antibody response following experimental urinary tract infection. Bahrani FK, Johnson DE, Robbins D, Mobley HL. Infect Immun; 1991 Oct 03; 59(10):3574-80. PubMed ID: 1680106 [Abstract] [Full Text] [Related]
14. Fimbriae of uropathogenic Proteus mirabilis. Rocha SP, Pelayo JS, Elias WP. FEMS Immunol Med Microbiol; 2007 Oct 03; 51(1):1-7. PubMed ID: 17640292 [Abstract] [Full Text] [Related]
15. Flagellate and non-flagellate Proteus mirabilis in the development of experimental urinary tract infection. Zunino P, Piccini C, Legnani-Fajardo C. Microb Pathog; 1994 May 03; 16(5):379-85. PubMed ID: 7815921 [Abstract] [Full Text] [Related]
17. cAMP receptor protein regulates mouse colonization, motility, fimbria-mediated adhesion, and stress tolerance in uropathogenic Proteus mirabilis. Tsai YL, Chien HF, Huang KT, Lin WY, Liaw SJ. Sci Rep; 2017 Aug 04; 7(1):7282. PubMed ID: 28779108 [Abstract] [Full Text] [Related]
18. Tissue-binding affinity of Proteus mirabilis fimbriae in the human urinary tract. Sareneva T, Holthöfer H, Korhonen TK. Infect Immun; 1990 Oct 04; 58(10):3330-6. PubMed ID: 1976113 [Abstract] [Full Text] [Related]
19. Evaluation of Proteus mirabilis structural fimbrial proteins as antigens against urinary tract infections. Pellegrino R, Galvalisi U, Scavone P, Sosa V, Zunino P. FEMS Immunol Med Microbiol; 2003 May 15; 36(1-2):103-10. PubMed ID: 12727373 [Abstract] [Full Text] [Related]
20. Construction of an MR/P fimbrial mutant of Proteus mirabilis: role in virulence in a mouse model of ascending urinary tract infection. Bahrani FK, Massad G, Lockatell CV, Johnson DE, Russell RG, Warren JW, Mobley HL. Infect Immun; 1994 Aug 15; 62(8):3363-71. PubMed ID: 7913698 [Abstract] [Full Text] [Related] Page: [Next] [New Search]